ACCM meeting #25, 16 July 2020

The meeting of the Advisory Committee on Complementary Medicines (ACCM).

The committee's advice and comment was sought on:

• Relevant aspects of microorganism characterisation for the purposes of establishing the quality and safety of applications relating to microorganisms for use in listed medicines and registered complementary medicines.
• The relationship between taste disturbance/loss-of-taste adverse events reported for products that contain Andrographis paniculata, and whether there is sufficient evidence to support restrictions to mitigate the risk of taste-related adverse events when used in listed medicines.
• The potential for Valeriana officinalis to cause herb-induced liver injury, and whether there is sufficient evidence to support restrictions to mitigate the risk of liver injury when used in listed medicines.

Members

Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.